Introduction
Hodgkin's disease (HD) is a malignant lymphoma characterized by the presence of mononucleated Hodgkin cells and multinucleated Reed-Sternberg cells (H ± RS cells) in a background of reactive cells comprising lymphocytes, eosinophils, plasma cells, histiocytic cells and ®broblasts (Harris, 1999; GruÈ ss and Kadin, 1996; Kadin and Liebowitz, 1999) . H ± RS cells represent an expansion of a single clone originating from a germinal center B cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription (Kuppers et al., 1994; Kanzler et al., 1996; Mara®oti et al., 2000) . The biological mechanisms involved in the growth regulation and death of H ± RS cells are not well understood. Constitutively activated nuclear factor-kB (NF-kB) (p50/p65) was reported to be a unique and common characteristic of H ± RS cells that triggers proliferation, and these cells were prevented from undergoing apoptosis (Bargou et al., 1996 (Bargou et al., , 1997 . Expression of various cytokines such as IL-13 and IL-5 by H ± RS cells de®nes clinical and histological characteristics of HD (Harris, 1999) and NF-kB is involved in transcriptional regulation of many cytokine genes (reviewed in Baldwin, 1996) . Thus, constitutively activated NF-kB may be a molecular mechanism related to aberrant growth and cytokine gene expression in H ± RS cells.
CD30, a member of the TNF receptor (TNFR) superfamily (DuÈ rkop et al., 1992; Smith et al., 1994; Falini et al., 1995; was originally found to be a surface molecule overexpressed on H ± RS cells (Schwab et al., 1982) . Crosslinking of CD30 by antibodies or its ligand (CD30L) (Smith et al., 1993) results in proliferation of HD-derived cell lines such as HDLM-2 and L428 (GruÈ ss et al., 1994) . It was shown that stimulation by exogenous CD30L from human eosinophils may stimulate the proliferation of Hodgkin's cells in vitro (Pinto et al., 1996) . This could potentially explain the worse prognosis of patients whose lymph nodes contain a high density of eosinophils (von Wasielewski et al., 2000) . Other investigators and our group have shown that CD30 signals leading to NF-kB activation are mediated by interactions with TNFR-associated factor (TRAF) 2 and 5 (Lee et al., 1996; Gedrich et al., 1996; Aizawa et al., 1997; Boucher et al., 1997) . Ligation of TNF superfamily members with their receptors, such as CD30, CD40, TNFRII, induces recruitment of TRAF proteins to the cytoplasmic tail of the receptor, and transduces signals to activate IKK that phosphorylates IkBa, the result being translocation of active NF-kB into the nucleus (reviewed in Baker and Reddy, 1998) .
In attempts to determine the molecular mechanisms by which the H ± RS cells grow and express immunoregulatory cytokines, we investigated the link between two major characteristics of H ± RS cells, i.e., CD30 overexpression and constitutive NF-kB activation. We report here that overexpression of CD30 results in a ligand-independent constitutive activation of NF-kB. Overexpression of CD30 leads to self-aggregation, recruitment of TRAF2 and TRAF5, the result being constitutive NF-kB activation. Co-localization of CD30 and TRAF proteins was also observed in H ± RS cells in biopsied lymph nodes of patients with Hodgkin's disease. This activation was blocked by coexpression of a decoy mutant of CD30 lacking the cytoplasmic region or a dominant negative TRAF2 or TRAF5, indicating that signals from CD30 lead to NF-kB activation. Blocking constitutive NF-kB activation by a dominant negative IkBa (Kanegae et al., 1998) or a decoy CD30 transduced by an adenovirus vector downregulated IL-13 expression and induced apoptosis of H ± RS cells. We interpret these ®ndings to mean that constitutive CD30 signaling is the basis for growth of tumor cells as well as for characteristic clinical and histological features of HD. Expression of a dominant negative IkB or a decoy CD30 transduced by an adenovirus vector may provide a basis for a new strategy of cell-and target molecule-speci®c gene therapy for HD.
Results

Overexpression of CD30 triggers activation of NF-kB
To determine whether or not the overexpression of CD30 triggers signal transduction in stable transformants, NF-kB activation was examined in electrophoretic mobility shift assays (EMSA). Without ligation by CD30L or use of a crosslinking antibody, 293-CD30wt cells but not 293-CD30D178 cells showed constitutive nuclear NF-kB activity ( Figure  1 , lanes 1 and 2). As has been reported (Bargou et al., 1996) , constitutive nuclear activation of NF-kB was clearly demonstrated in H ± RS cell-derived cell lines HDLM2 and L428 (Figure 1 , lanes 4 and 5). Since CD30L is not expressed in HEK293 cells and its transformants (data not shown), nor in H ± RS cell lines (Hsu and Hsu, 2000) , autocrine or paracrine activation of CD30 is highly unlikely. On the other hand, the possibility that an unknown soluble factor may interact with CD30 and triggers signaling can be ruled out, because in the culture supernatants of these cell lines there is abundant soluble CD30 formed by cleavage of the extracellular domain (JosimovicAlasevic et al., 1989) and which has a neutralizing eect against CD30L. Thus, the results indicate that overexpression of CD30 is associated with NF-kB activation, which depends on the cytoplasmic region of CD30.
Self-association of CD30 through extracellular and cytoplasmic regions recruits TRAF2 and TRAF5
To investigate the mechanism by which CD30 overexpression leads to signal transduction, we ®rst tested the possibility that CD30 overexpression by itself results in self-association of extracellular and/or cytoplasmic regions. The 293-CD30wt or 293-CD30D178 cells were transfected with an expression vector for a histidine-tagged cytoplasmic region (HisCD30c) or a mutant lacking the cytoplasmic region that was FLAG-tagged at the C-terminus (CD30D178-FLAG). Cell lysates were immune-precipitated either with Ber-H2 or with an anti-FLAG M2 antibody. The immunoprecipitates were examined by immunoblot for co-immunoprecipitation, using Anti-Xpress TM antibody or Ber-H2. Results showed that the wild-type CD30 co-immunoprecipitated with the cytoplasmic region (Figure 2a ), whereas the deletion mutant (CD30D178) did not (Figure 2a) . Furthermore, this mutant also coimmunoprecipitated with the wild-type CD30 ( Figure  2b ). These results indicate that both extracellular and cytoplasmic regions of CD30 protein can self-associate in vivo.
Next we asked if overexpressed CD30 recruits endogenous TRAF proteins without interaction with CD30L. As shown in Figure 2c (lanes 1 ± 3) To con®rm the recruitment of TRAF proteins by overexpressed CD30 protein, we examined the intracellular localization of TRAF proteins in stable transformants and H ± RS-derived cell lines, using confocal immuno¯uorescence microscopy. In 293-CD30wt cells, co-localization of TRAF5 or TRAF2 with CD30 near the cell membrane was clearly demonstrated (Figure 3a , upper panels). On the other hand, 293-CD30D178 cells showed no co-localization of TRAF proteins with CD30, and most of the TRAF proteins were present in the cytoplasm (Figure 3a , lower panels). A similar co-localization of TRAF proteins and CD30 was observed in H ± RS derived cell lines, HDLM2 and L428 ( Figure 3b , upper and lower panels). In these lines, both TRAF proteins were abundantly expressed with some scattered cytoplasmic distribution, unassociated with CD30. Importantly, colocalization of TRAF proteins with CD30 was also con®rmed in H ± RS cells of Hodgkin's disease lymph nodes (Figure 3c ). Taken collectively, the results suggest that overexpressed CD30 proteins self-assemble and constitutively recruit TRAF proteins independent of its ligand, thereby triggering signaling to activate NF-kB.
Co-expression of a decoy CD30 abrogates recruitment of TRAF proteins and signal transduction
We next determined if the co-expression of CD30 mutants that lack the C-terminal TRAF binding region (CD30D95) (Lee et al., 1996; Gedrich et al., 1996; Aizawa et al., 1997; Boucher et al., 1997) or most of the cytoplasmic region (CD30D178) interfered with interactions between TRAF proteins and CD30. When the FLAG-tagged TRAF2 or TRAF5 were transiently expressed in HEK293T cells along with the wild-type CD30, they co-immunoprecipitated with CD30 protein (Figure 4a , lanes 2 and 6). Whether or not co-expression of the CD30D178 mutant would inhibit the co-localization of TRAF proteins with the wild-type CD30 was then determined. After transfection of the CD30D178-FLAG plasmid into the 293-CD30wt cells, localization of the TRAF proteins was analysed, using confocal immuno¯uores-cence microscopy. Overexpression of the CD30D178-FLAG abolished the membrane localization of TRAF2 (Figure 4b, left panel) . Overexpression of the wild-type CD30 did not result in co-localization with TRAF2 in 293-CD30D178 cells (Figure 4b , right panel), suggesting inhibition by the presence of CD30D178 protein.
Since the disruption of co-localization suggests a halt in CD30 signaling, we determined if NF-kB activation by CD30 overexpression would be inhibited by expression of CD30 mutants lacking the TRAF binding domain by reporter gene analysis using NFkB-driven luciferase construct. As expected, the CD30 mutants inhibited the constitutive NF-kB activation in 293-CD30wt cells and H ± RS cell lines as eciently as did dominant negative forms of TRAF2 and TRAF5 ( Figure 4c , left and right panels, respectively). Cotransfection of unrelated proteins such as b-galactosidase showed no eects on the NF-kB-driven luciferase activity (data not shown). These results indicate that co-expression of CD30 mutants without the cytoplasmic tail can inhibit recruitment of TRAF proteins and abrogate downstream activation of NF-kB, presumably by blocking aggregation of the cytoplasmic tail of the wild-type CD30 protein. They also indicate that NF-kB activation in these cells is driven by the CD30-TRAF pathway, thereby providing support for the notion that overexpression of CD30 by itself drives NF-kB activation in H ± RS cells.
Efficient infection of Hodgkin cells by adenovirus vector and apoptosis induction by a dominant negative IkB mutant
In the search for an ecient method of gene transfer into H ± RS cells (HDLM2, L428 and L540), we found that an adenovirus vector can eciently infect H ± RS cell lines (Figure 5a , left panel), indicating that H ± RS cells are good targets for an adenovirus vector. So far, we have tested seven H ± RS cell lines including L540 and con®rmed that they are all highly susceptible to the adenovirus vector (data not shown). We next found that overexpression of mIkBa or a decoy CD30 by the adenovirus vectors (AxCAIkB-M or AxCACD30D), but not infection of a vacant adenovirus vector, in H ± RS cell lines down regulated NF-kB activity ( Figure  5a , right panel), and mRNA and protein expression of IL-13 depicted by Northern blot analysis and ELISA (Figure 5b , left and right panels, respectively). AxCACD30D infection of L428 also resulted in downregulation of IL-13 production, although the level of suppression was smaller (data not shown). Moreover, transduction of mIkBa or a decoy CD30 resulted in cell death of H ± RS-derived cells within 2 ± 3 days (Figure 5c ), whereas no change in the viability was observed by infection of AxNluI (data not shown), DNA fragmentation and fragmented nuclei were clearly observed in cells infected by AxCAIkB-M but not cells infected by a vacant adenovirus vector ( Figure  5d ). These results indicate that inhibition of NF-kB induces apoptosis of H ± RS cells. Thus, adenovirus vector-mediated introduction of the mIkBa or a decoy CD30 may prove to be a novel strategy of cell-and target molecule-speci®c gene therapy to eliminate H ± RS cells.
Discussion
Activated NF-kB consisting of p50 and p65 is the hallmark of H ± RS cells in lymph node biopsy samples from patients with HD and cell lines derived from those cells (Bargou et al., 1996 (Bargou et al., , 1997 , and is essential for both proliferation and survival of H ± RS cells. In the present study, we demonstrated that constitutive NF-kB activation in H ± RS cells is driven by ligandindependent signaling from overexpressed CD30. This conclusion is based on the observations that: (1) NFkB is activated in HEK293 transformants (293-CD30wt cells) that overexpress CD30; (2) CD30 and TRAF proteins co-localized in the H ± RS cells in HD lymph nodes and cell lines derived from them, as well as in 293-CD30wt cells; (3) CD30 overexpression leads to self-aggregation and co-expression of CD30 mutants lacking the C-terminal region abrogated interactions between CD30 and TRAF proteins; and (4) NF-kB activation is suppressed in CD30 overexpressing cells by blocking CD30-TRAF signaling pathways with decoy CD30 mutants and dominant negative TRAF proteins. Together, these observations collectively indicate that ligand-independent assembly of overexpressed CD30 in H ± RS cells recruits TRAF 2 and TRAF5 and consistently triggers downstream signaling. These events result in apparently constitutive, but CD30-dependent activation of NF-kB in H ± RS cells. Mutation of IkBa has been implicated in aberrant constitutive NF-kB activation in H ± RS cells (Heinemeyer et al., 1998; Wood et al., 1998; Emmerich et al., 1999; Cabannes et al., 1999) . However, this cannot explain constitutive activation of IKKa in these cells (Kapp et al., 1999) , nor our ®nding that NF-kB activation is blocked by dominant negative TRAF proteins even in L428 cells with defective IkBa (Figure 4e ). Thus, our data indicate that irrespective of the presence or absence of mutations in IkBa, overexpressed CD30 drives NF-kB activation in H ± RS cells.
Signaling in the TNFR superfamily was considered to be triggered by the trimerized form of cognate ligands that induce assembly of the receptor (Baker and Reddy, 1998) . However, it was reported that selfassociation through the extracellular and cytoplasmic domains of the TNFR superfamily members can prompt signaling events (Song et al., 1994 HEK293T cells, expression vectors of the wild-type CD30 and FLAG-tagged TRAF proteins (0.5 mg each) were transiently cotransfected with or without that of a mutant CD30. Vacant pME18s was used to make the total amount of transfected plasmids to always be 2 mg. Cells were lysed in 1 ml of TNE buer and 20 ml aliquots were used immunoblot analysis of whole cell lysates. Immunoprecipitation was done with Ber-H2 antibody that recognize the extracellular region of CD30. The immunoprecipitates were blotted with anti-FLAG M2 antibody to detected co-immunoprecipitated TRAF proteins (upper panel). Whole cell lysates were blotted with either Ber-H2 or M2 antibody to con®rm expression of CD30 proteins and FLAG-tagged TRAF proteins (middle and lower panels, respectively). (b) Abrogation of co-localization of CD30 and TRAF2 in the presence of a mutant CD30. Confocal microscopy of 293-CD30wt transfected with the FLAG-tagged CD30D178 (left panel) and 293-CD30D178 with the wild-type CD30 (right panel). CD30 and CD30D178-FLAG protein were detected by BerH2 and M2 antibody, respectively, using a Texas-Redlabeled anti-mouse IgG antibody as the secondary antibody. TRAF2 protein was detected by a rabbit polyclonal antibody and a FITC-labeled anti-rabbit immunoglobulin antibody (left panel). The wild-type CD30 in 293-CD30D178 was detected by the anti-C- Wu et al., 1999) . As to CD30, we reported that transient overexpression of the wild-type protein or a variant form that only retains the cytoplasmic region (CD30v) triggers signals to activate NF-kB (Aizawa et al., 1997; Horie et al., 1996 . In the present study, we found that extracellular and cytoplasmic domains of CD30 can self-associate, this association was required for recruitment of TRAF2 and TRAF5 and the subsequent NF-kB activation, since co-expression of a decoy mutant CD30 lacking the cytoplasmic region inhibited interaction with TRAF proteins and abolished NF-kB activation.
Aberrant overexpression of many cytokines by H ± RS cells de®nes the clinical and histological characteristics of HD (Harris, 1999; Cossman et al., 1999; Kapp et al., 1999) . Since NF-kB regulates transcription of most of these cytokines, NF-kB activation may well be the basis for this aberrant cytokine expression. Supporting this hypothesis, constitutive IL-13 expression by H ± RS cells was downregulated by blocking NF-kB by a dominant negative IkBa (Figure 5b ). Although regulation of the IL-13 promoter by NF-kB has not been reported, computer analysis of the promoter sequence by TSEARCH program (Heine- meyer et al., 1998) revealed two typical binding sites for NF-kB. Thus, our results strongly suggest that NFkB activation by CD30 drives expression of IL-13, which is commonly overexpressed in H ± RS cells in vivo. Collectively, constitutive activation of NF-kB resulting from ligand-independent signaling by overexpressed CD30 appears to be the critical molecular mechanism that de®nes the clinical and histological basis of HD.
We found that a mutant CD30 lacking the cytoplasmic region inhibits NF-kB activation by CD30, results which indicate that the mutant can function as a decoy antagonist receptor for CD30. These ®ndings are reminiscent of an antagonist decoy receptor TRID or DcR1, a decoy receptor for TRAIL (Pan et al., 1997; Sheridan et al., 1997) . TRID or DcR1 is homologous to DR4 and DR5 but lacks the intracellular domain and inhibits death-inducing signals from DR4 and DR5 when co-expressed, thus functioning as an antagonist for DR4 and DR5. Although the mechanisms by which CD30D178 inhibits NF-kB were not directly addressed, inhibition of TRAF recruitment to CD30 suggest a possible mechanism by which the mutant CD30 intercalates overexpressed CD30 and inhibits assembly of the cytoplasmic region. This notion is supported by our previous observation that overexpression of CD30v that corresponds to the cytoplasmic region of CD30 can recruit TRAF proteins and activate NF-kB (Horie et al., 1996) , and by observations that the extracellular domain of other TNFR family receptors like TNFR1 and Fas mediates oligomerization (Papo et al., 1999; Chan et al., 2000; Siegel et al., 2000) .
Our observation that abundant TRAF2 was demonstrated in the H ± RS cell lines and 293-CD30wt cells (Figure 3,a,b) does not support the model proposed by in which CD30 limits its own potential to transduce cell survival signals through signal-coupled depletion of TRAF2 . Although the reason for this discrepancy is not clear, it may be due to the fact that the model is based on experiments employing transient overexpression of CD30 , whereas we used cell lines that constitutively overexpress CD30.
We examined the feasibility of adenovirus vectorbased strategies for delivering a dominant negative IkBa and a decoy CD30 to induce apoptosis of H ± RS cells. Although earlier studies suggested a low eciency of adenovirus vector transduction in normal PBMCs and hematological malignancies, more recent reports demonstrated successful adenovirus transduction into human chronic lymphocytic leukemia B cells and multiple myeloma cells (Cantwell et al., 1996; Medina et al., 1999; Prince et al., 1998; Teoh et al., 1998) . We found that adenovirus vectors have a high transduction eciency (up to 100%) in H ± RS cells. Importantly, transduction of AxCAIkB-M or a decoy CD30 induced apoptosis in H ± RS cells within 2 ± 3 days, thereby indicating that ecient blocking of the NF-kB activity by itself can induce apoptosis of H ± RS cells.
We conclude that overexpression of CD30 in H ± RS cells results in ligand-independent signaling through self-assembly mediated by extracellular and cytoplasmic domains. This ®nding demonstrates a previously unrecognized link between two well known phenotypic characteristics of H ± RS cells, namely CD30 overexpression and the constitutive activation of NF-kB. H ± RS cells can be eciently infected by an adenovirus vector, blocking NF-kB activation which resulted in downregulation of cytokine expression and apoptotic cell death. These ®ndings can lead to a novel strategy for cell-and target molecule-speci®c gene therapy in patients with HD.
Materials and methods
Cell cultures and adenovirus production
The Jurkat, HEK293, and HEK293T cell lines were obtained through the Japanese Cancer Research Resources Bank (Tokyo, Japan) and Fujisaki Cell Biology Center (Okayama, Japan), while HDLM-2, L428 and L540 cell lines were purchased from the German Collection of Micro-organisms and Cell Cultures (Braunschweig, Germany). Cell lines were cultured in standard condition in RPMI 1640 or DMEM supplemented with recommended amounts of FCS. Preparation of recombinant adenoviruses, AxCAGFP and AxCAmIkB-M, was as described elsewhere (Kanegae et al., 1998) .
Isolation of stable transformants of wild-type and mutant CD30
Expression vectors for the wild-type and a mutant human CD30 (pME ± hCD30 and pCR ± hCD30 (D178)), as well as a vacant vector, were transfected with pRSV ± Neo into HEK293 cells, using Lipofectin 1 reagent (GIBCO ± BRL). Cells were selected with 400 mg/ml of G418 (GIBCO ± BRL), and surviving cells were cloned by limiting dilution. Expression of transduced constructs in HEK293 cells was con®rmed, using immunoblot analysis and¯ow cytometry with Ber-H2 antibody. Three clones were selected for each transformant, and subjected to analysis.
Plasmids and cDNA
The expression vectors for human CD30 and its mutants were as described elsewhere . That for Histidine-tagged cytoplasmic region containing C-terminal 132 aa of CD30 was prepared using PCR. Plasmids that express FLAG-tagged TRAF2 and TRAF5, and those for truncated TRAF2 and TRAF5 proteins retaining only the TRAF domain were as described elsewhere (Aizawa et al., 1997) . The C-terminally FLAG-tagged CD30D178 was constructed, using pME-FLAG vector.
Co-immunoprecipitation and immunoblotting
Immunoblotting experiments to detect expression of the transduced gene and co-immunoprecipitation were done, as described (Horie et al., 1996) . Transfection was done by Lipofectin reagent (Invitrogen) using 2610 6 HEK293T cells and total of 2 mg of expression vectors. A vacant expression vector pME18S was used for control transfections or to make the total amount of transfected plasmid to be 2 mg. For coimmunoprecipitation analyses, cell lysates were prepared NF-kB activation by overexpressed CD30 in H ± RS cellsfrom 2610 6 or 1610 7 cells in TNE buer (10 mM Tris-HCl, pH 7.8, 1% Nonidet P-40, 150 mM NaCl, 1 mM EDTA). When indicated, aliquots were removed for immunoblots of whole cell lysates. Anti-CD30 mouse monoclonal antibody (BerH2) (DAKO), anti-C-terminal CD30 goat antibody (Santa Cruz), anti-TRAF2 rabbit antibody (Santa Cruz), anti-TRAF5 rabbit antibody (Santa Cruz), Anti-Xpress TM (Invitrogen) and anti-FLAG monoclonal antibody (M2) (Kodak) were used. Antibody binding was detected, using ECL chemiluminescence kits (Amersham). Secondary antibodies used are as follows: Peroxidase-conjugated anti-goat immunoglobulin rabbit antibody (Sigma), HRP-linked antimouse immunoglobulin sheep antibody and HRP-linked antirabbit donkey antibody (both from Amersham Pharmacia Biotech).
Reporter gene assays
Reporter gene assay to detect NF-kB activity was done, using a kB-site dependent luciferase vector p6xkB-Luc, as described (Aizawa et al., 1997) . Renilla luciferase expression vector driven by the herpes simplex virus thymidine kinase promoter (pRL-TK, Promega) was co-transfected to standardize each experiment. For each transfection, 0.5 mg of p6xkB-Luc, 0.2 mg of pRL-TK and 0.5 mg of the indicated expression vector or a vacant pME18S were used. For HEK293-derived cells, 5610 4 cells were transfected using Lipofectin (In Vitrogen). For H ± RS cell-derived cell lines, 2610 5 cells were transfected using DMRIE-C (In Vitrogen). Cells were harvested 48 h after transfection, and Luciferase activity was measured by Dual Luciferase assay kit (Promega). Representative results of triplicated experiments with mean and standard deviation are shown in the ®gures.
Electrophoretic mobility shift analysis (EMSA)
A double-stranded oligonucleotide containing the mouse immunoglobulin kappa (Igk) light-chain NF-kB consensus site (5'-AGTTGAGGGGACTTTCCCAGGC-3') was purchased from Promega. Nuclear extracts were prepared basically according to the method reported by Andrews and Faller (1991) . Brie¯y, cells were washed in cold phosphate buered saline (PBS), and suspended in buer A (10 mM HEPES ± KOH pH 7.9 at 48C, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol, 0.2 mM PMSF9. After brief vortexing, samples were centrifuged and the pellet is resuspended in 50 ml of cold buer C (20 mM HEPES ± KOH pH 7.9 at 48C, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM dithiothreitol, 0.2 mM PMSF) and incubated for 20 min for high salt extraction. Cellular debris was removed by centrifugation and the supernatant fraction was used as nuclear extract. For binding assays, 5 mg samples of the nuclear extracts were incubated with approximately 20 000 c.p.m. of g-32 P end-labeled probe at room temperature for 30 min in a buer containing 20 mM HEPES (pH 7.9), 50 mM KCl, 0.5 mM EDTA, 5% glycerol, 1 mM DTT, 0.1% NP-40, 0.5 mM PMSF, 1 mg/ml BSA, 2 mg Poly (dI-dC). DNA-protein complexes were resolved on 5% polyacrylamide gels in 0.56TBE buer. The gels were then dried and autoradiographed.
Transduction experiments
Recombinant replication-de®cient adenoviruses, AxCAGFP and AxCAIkB-M were as described elsewhere (Kanegae et al., 1998) . An adenovirus carrying a decoy mutant of CD30 (CD30D178) was prepared using COS ± TPC method as described (Miyake et al., 1996) and named AxCACD30D. AxNluI is the vacant vector. AxCAGFP is a control virus that contains the gene for humanized green¯uorescent protein (hGFP), and AxCAIkB-M contains nonphosphorable IkBa. Cells were plated in 10-cm culture dishes. After 24 h, the medium was changed and viral vectors were added at a multiplicity of infection (m.o.i.) 100. After 2 h of incubation, the virus-containing medium was replaced with fresh medium, and cells were incubated for indicated periods to allow for gene expression. Successful transduction was con®rmed by¯ow-cytometry and laser confocal microscopy.
Immunohistochemistry
Adherent cultured cells were grown on coverslips for 1 day, rinsed in TBS with 2% BSA and ®xed with 100% methanol for 10 min. Cells in suspension culture was ®rst washed twice in TBS with 2% BSA. Cytospin samples were prepared using 1610 4 cells and ®xed with 100% methanol for 10 min. After ®xation, cells were washed three times in water and rinsed in TBS. Samples were ®rst incubated with a mixture of anti-CD30 (BerH2) and anti-TRAF2 or TRAF5 antibodies at the concentration of 5 mg/ml each. When indicated, anti-FLAG antibody (M2) or anti-C-terminal CD30 antibody was used instead of BerH2. After incubation with¯uorescence-labeled secondary antibodies for 30 min at room temperature, samples were washed three times with TBS and covered with a FluoroGuard antifade reagent (Bio-Rad). Fluorescence signals were detected using confocal microscopy (Radiance 2000, Bio-Rad). Secondary antibodies with a¯uorochrome used in these studies are as follows: FITC-labeled anti-mouse immunoglobulin sheep antibody, Texas-Red-labeled antimouse immunoglobulin sheep antibody, FITC-labeled antirabbit donkey antibody, Texas-Rad-labeled anti-rabbit donkey antibody (all from Amersham Pharmacia Biotech); FITC-labeled anti-goat donkey antibody (Santa Cruz). Sections of formalin-®xed and paran-embedded lymph node samples were ®rst autoclaved for 15 min in 10 mM citrate buer (pH 6.0) and washed three times in distilled water and rinsed in TBS. To detect CD30 and TRAF proteins, a modi®cation of the tyramide signal ampli®cation (TSA) system (NEN Life Science) was used in order to facilitate use of streptavidine-FITC or streptavidine ± Texas Red instead of peroxidase-conjugated streptavidine. Signals were detected, using the confocal microscopy.
Detection of apoptosis
DNA fragmentation in apoptotic cells was detected, using ApoAlert DNA Fragmentation Assay Kits (Clontech) and according to the manufacturer's instructions with H ± RS cells ®xed on poly-L-lysine-coated slides. Cells were analysed by ā uorescence microscope using FITC/PI dual pass ®lter. For DAPI (4',6-Diamidino-2-phenilindole-dihydrochloride) staining, cells were covered by DAPI solution (0.01 mg/ml) and incubated at room temperature for 15 min. Cells were photographed by a¯uorescence microscope.
